RBC Capital maintained an Underperform rating and $5 price target on Palantir after the National Health Service awarded Palantir and four other IT professional services and consultant firms a GBP 330M contract over seven years. RBC views the announcement as “underwhelming,” as the contract was smaller than expected and is split between four other firms.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PLTR: